Acquisition History / ClearPoint Neuro, Inc. / IRRAS Holdings, Inc.

ClearPoint Neuro, Inc. Acquires IRRAS Holdings, Inc.

Announced November 20, 2025 — $5M

ClearPoint Neuro, Inc.Neurocritical care medical devices2025

What happened

ClearPoint Neuro, a device, cell and gene therapy-enabling company offering navigation to the brain and spine, completed the acquisition of IRRAS on November 20, 2025 to expand its commercial scale. It paid $5.0M in cash and issued 1,325,000 shares of common stock to IRRAS shareholders.

Acquirer
ClearPoint Neuro, Inc.
Target
IRRAS Holdings, Inc.
Announced
November 20, 2025
Price
$5M
Industry
Neurocritical care medical devices
Buyer type
Strategic acquirer
Status
Closed

By the numbers

ClearPoint Neuro, Inc.'s acquisition history
1st of 1 tracked deals
Disclosed prices
1 of 1 ClearPoint Neuro, Inc. deals
ClearPoint Neuro, Inc.'s average disclosed price
$5M
ClearPoint Neuro, Inc.'s largest disclosed deal
IRRAS Holdings, Inc. ($5M)
Tracked acquisitions in 2025
503 across all acquirers
ClearPoint Neuro, Inc. in Neurocritical care medical devices
1 acquisition

Frequently Asked Questions About This Acquisition

When did ClearPoint Neuro, Inc. acquire IRRAS Holdings, Inc.?

ClearPoint Neuro, Inc. acquired IRRAS Holdings, Inc. on November 20, 2025. This was ClearPoint Neuro, Inc.'s 1st publicly tracked acquisition out of 1 we have on record.

How much did ClearPoint Neuro, Inc. pay for IRRAS Holdings, Inc.?

ClearPoint Neuro, Inc. paid $5M for IRRAS Holdings, Inc..

What does IRRAS Holdings, Inc. do?

ClearPoint Neuro, a device, cell and gene therapy-enabling company offering navigation to the brain and spine, completed the acquisition of IRRAS on November 20, 2025 to expand its commercial scale. It paid $5.0M in cash and issued 1,325,000 shares of common stock to IRRAS shareholders.

What other Neurocritical care medical devices companies has ClearPoint Neuro, Inc. acquired?

IRRAS Holdings, Inc. is ClearPoint Neuro, Inc.'s only publicly tracked acquisition in Neurocritical care medical devices so far.

Read the full article →